Date
2020-11-24Journal
BMJ (Clinical research ed.)Publisher
BMJ Publishing GroupType
Article
Metadata
Show full item recordIdentifier to cite or link to this item
http://hdl.handle.net/10713/14216ae974a485f413a2113503eed53cd6c53
10.1136/bmj.m4560
Scopus Count
Related articles
- Assessing the evidence on remdesivir.
- Authors: Trøseid M, Hites M, Barratt-Due A, Ader F, Yazdanpanah Y
- Issue date: 2021 Dec
- Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.
- Authors: Nili A, Farbod A, Neishabouri A, Mozafarihashjin M, Tavakolpour S, Mahmoudi H
- Issue date: 2020 Nov
- Remdesivir for patients with COVID-19.
- Authors: Wu PE, Morris AM
- Issue date: 2021 Jan 25
- [The medicinal treatment of COVID-19: a brief update].
- Authors: de Boer MGJ, Gieling EM, van der Linden PD, Sinha BNM, Vollaard AM
- Issue date: 2020 Nov 12
- Remdesivir as a broad-spectrum antiviral drug against COVID-19.
- Authors: Hong YN, Xu J, Sasa GBK, Zhou KX, Ding XF
- Issue date: 2021 Jan